by Ashley Moore
These 3 biotech stocks to watch are all positioned to rise with a common catalyst.
Analysts think this upcoming catalyst could cause one of these biotech stocks to gain nearly 140% in the next 12 months.
Here's what you need to watch with these biotech stocks in 2017...
by Stephen Mack
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
2017 is shaping up to be an exciting year for the top tech stocks. Let's take a look at four major areas of tech investing¬: marijuana, pharmaceuticals, the online revolution, and the car of the future.
by Ashley Moore
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
The top three stocks to watch today are INCY, CENX, and AMD.
Yesterday, President Trump went back on four campaign promises, one of which affects Fed Chair Janet Yellen.
Here's what you need to know this morning...
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
Chemotherapy and radiation have been cancer treatments since the 1950s, and in the meantime, science has developed more than 200 drugs to fight cancer.
All these established treatments have one thing in common. They're all more or less "one size fits all" treatments, procedures, or regimens.
But out on the frontier of cancer research where, as I've said, the most exciting, promising discoveries (and biggest profits) are made, there's a treatment under development that's going to disrupt the field for the next several decades.
I'm talking about powerful "bespoke" cancer treatments for every patient, using their own bodies to boot.
Not only will this improve and save lives, but it'll crack open a market worth $25 billion by 2025.
It really is a revolutionary development.
But the "Buy" call I'm making today is still trading at "pre-revolutionary" prices...
Start the conversation